CCO Treatment Updates
Treatment Update on T-Cell Lymphoma
Module
Recent Clinical Advances and Research Developments in T-Cell Lymphomas
- Owen A. O'Connor, MD, PhD
|
|
|
Owen A. O'Connor, MD, PhD, provides a comprehensive overview on standard and emerging agents and approaches for the treatment of T-cell lymphomas.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Summarize the epidemiology and pathophysiology of T-cell lymphomas
- Describe standard and emerging treatment options for patients with T-cell lymphomas
- Differentiate clinical presentation and diagnosis of cutaneous T-cell lymphomas vs peripheral T-cell lymphomas
Abstract
|
Interactive Virtual Presentations
Current and Emerging Treatment Options for Patients With Peripheral T-Cell Lymphoma
|
|
|
Steven M. Horwitz, MD, discusses current and emerging treatment options for patients with peripheral T-cell lymphoma.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Discuss the current standard of care for patients with peripheral T-cell lymphomas
- Compare the efficacy of CHOP with emerging options for the treatment of peripheral T-cell lymphomas
- Describe emerging novel agents for the treatment of peripheral T-cell lymphomas
- Analyze the role of stem cell transplantation in the treatment of peripheral T-cell lymphomas
|
Slideset: Current and Emerging Treatment Options for Patients With Peripheral T-Cell Lymphoma
 |
|
Downloadable slideset on the standards of care and emerging novel therapies for the treatment of peripheral T-cell lymphoma.
Format: Microsoft PowerPoint (.ppt) |
File size: 1.81 MB
| Date posted: 10/20/2009
|
Current and Emerging Treatment Options in Cutaneous T-cell lymphoma
|
|
|
John A. Zic, MD, discusses the pathogenesis, staging, and treatment options for patients with cutaneous T-cell lymphoma.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Discuss the pathogenesis of mycosis fungoides and Sézary syndrome, the most common variants of cutaneous T-cell lymphomas
- Describe the prognostic groups of cutaneous T cell lymphomas
- Summarize the therapeutic overview and treatment algorithm for treating cutaneous T-cell lymphoma patients
- Cite the efficacy and safety profiles of standard and emerging therapeutic options for treating patients with cutaneous T-cell lymphoma
|
Slideset: Current and Emerging Treatment Options in Cutaneous T-Cell Lymphoma
 |
|
Downloadable slideset on the standards of care and emerging novel therapies for the treatment of cutaneous T-cell lymphoma.
Format: Microsoft PowerPoint (.ppt) |
File size: 4.01 MB
| Date posted: 10/21/2009
|
Disclaimer:
The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.
|
Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.
Contact Info
Educational grants provided by:
Educational grants support only the CME-certified components of this program.
|
|